Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in Los Angeles, CA
NPI: 1023243748Primary Employer
USC Care Medical Group, Inc
keckmedicine.org
HQ Phone
Get M.D. Danielle's Phone NumberMobile
Get M.D. Danielle's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2021 - 2025
IL State Medical License
2012 - 2023
IN State Medical License
2015 - 2017
CA State Medical License
IL State Medical License
American Board of Internal Medicine
Hematology
American Board of Internal Medicine
Medical Oncology
Loyola University Medical Center
Fellowship • Hematology and Medical Oncology
2012 - 2015
McGaw Medical Center of Northwestern University
Residency • Internal Medicine
2009 - 2012
University of Arkansas For Medical Sciences College of Medicine
Medical School
Until 2009
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 276 | 759 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 115 | 275 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 33 | 33 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 30 | 51 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 29 | 29 |
Authors: Andrew Evens, Leo Gordon, Leo Gordon
Journal: Curr Oncol Rep
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, DRUG: Topotecan Hydrochloride, DRUG: Olaparib, DRUG: Paclitaxel, PROCEDURE: Computed Tomography with Contrast, PROCEDURE: Computed Tomography, BIOLOGICAL: Durvalumab, PROCEDURE: Multigated Acquisition Scan, DRUG: Pegylated Liposomal Doxorubicin Hydrochloride, PROCEDURE: Echocardiography Test, DRUG: Cediranib Maleate
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, OTHER: Best Practice, OTHER: Educational Intervention, BEHAVIORAL: Motivational Interviewing, OTHER: Text Message-based Navigation Intervention
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Niraparib